PD-L1 Protein (DYKDDDDK Tag)
Kurzübersicht für PD-L1 Protein (DYKDDDDK Tag) (ABIN2713592)
Target
Alle PD-L1 Proteine anzeigenProtein-Typ
Spezies
Quelle
Applikation
Reinheit
-
-
Aufreinigungstag / Konjugat
- Dieses PD-L1 Protein ist gelabelt mit DYKDDDDK Tag.
-
Produktmerkmale
-
- Recombinant human CD274 / PDL1 (C-term DDK tag) protein expressed in Sf9 cells.
- Produced with end-sequenced ORF clone
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Kommentare
-
The tag is located at the C-terminal.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 50 μg/mL
-
Buffer
- 50 mM Tris-HCl, pH 8.0, 100 mM glycine, 10 % glycerol.
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- Cd274,pdl1
-
Hintergrund
- This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
- 31 kDa
-
NCBI Accession
- NP_054862
-
Pathways
- Cancer Immune Checkpoints
Target
-